• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中二分类和有序结局的联合评分检验。

A combined score test for binary and ordinal endpoints from clinical trials.

机构信息

Department of Mathematics and Statistics, Lancaster University, Lancaster, UK.

出版信息

Stat Med. 2010 Feb 28;29(5):521-32. doi: 10.1002/sim.3822.

DOI:10.1002/sim.3822
PMID:20082364
Abstract

There is growing interest, especially for trials in stroke, in combining multiple endpoints in a single clinical evaluation of an experimental treatment. The endpoints might be repeated evaluations of the same characteristic or alternative measures of progress on different scales. Often they will be binary or ordinal, and those are the cases studied here. In this paper we take a direct approach to combining the univariate score statistics for comparing treatments with respect to each endpoint. The correlations between the score statistics are derived and used to allow a valid combined score test to be applied. A sample size formula is deduced and application in sequential designs is discussed. The method is compared with an alternative approach based on generalized estimating equations in an illustrative analysis and replicated simulations, and the advantages and disadvantages of the two approaches are discussed.

摘要

人们对在单一临床试验评估中结合多个终点指标来评估实验性治疗方法的兴趣日益浓厚,这种方法尤其适用于中风试验。终点指标可以是对同一特征的多次重复评估,也可以是不同量表上进展情况的替代衡量指标。这些终点指标通常为二分类或有序分类变量,本研究也主要针对这两种情况。本文直接对每种终点指标的单变量评分统计量进行组合,推导评分统计量之间的相关性,并利用相关性进行有效的综合评分检验。本文还推导出一个样本量公式,并讨论了序贯设计中的应用。在一个说明性分析和复制模拟中,本文将这种方法与基于广义估计方程的替代方法进行了比较,并讨论了两种方法的优缺点。

相似文献

1
A combined score test for binary and ordinal endpoints from clinical trials.临床试验中二分类和有序结局的联合评分检验。
Stat Med. 2010 Feb 28;29(5):521-32. doi: 10.1002/sim.3822.
2
Multiple-arm superiority and non-inferiority designs with various endpoints.具有多种终点的多臂优效性和非劣效性设计。
Pharm Stat. 2007 Jan-Mar;6(1):43-52. doi: 10.1002/pst.242.
3
Sample size determination in clinical trials with multiple co-primary binary endpoints.临床试验中具有多个主要二分类结局指标的样本量确定。
Stat Med. 2010 Sep 20;29(21):2169-79. doi: 10.1002/sim.3972.
4
A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint.一种使用二元替代终点来预测干预对真实终点影响的简单荟萃分析方法。
Biostatistics. 2006 Jan;7(1):58-70. doi: 10.1093/biostatistics/kxi040. Epub 2005 Jun 22.
5
A mixed approach for proving non-inferiority in clinical trials with binary endpoints.一种用于证明具有二元终点的临床试验中不劣效性的混合方法。
Biom J. 2008 Apr;50(2):190-204. doi: 10.1002/bimj.200710410.
6
Addressing multiplicity issues of a composite endpoint and its components in clinical trials.解决临床试验中复合终点及其组成部分的多重性问题。
J Biopharm Stat. 2011 Jul;21(4):610-34. doi: 10.1080/10543406.2011.551327.
7
Sample-size calculations for studies with correlated ordinal outcomes.具有相关有序结局的研究的样本量计算。
Stat Med. 2005 Oct 15;24(19):2977-87. doi: 10.1002/sim.2162.
8
Improving the estimation of change from baseline in a continuous outcome measure in the clinical trial setting.在临床试验环境中改进连续结果测量相对于基线变化的估计。
Contemp Clin Trials. 2005 Feb;26(1):2-16. doi: 10.1016/j.cct.2004.08.008. Epub 2005 Jan 27.
9
Design and analysis of crossover trials for absorbing binary endpoints.吸收性二元终点交叉试验的设计与分析
Biometrics. 2010 Sep;66(3):958-65. doi: 10.1111/j.1541-0420.2009.01358.x.
10
Robustness and power of analysis of covariance applied to ordinal scaled data as arising in randomized controlled trials.应用于随机对照试验中出现的有序尺度数据的协方差分析的稳健性和功效。
Stat Med. 2003 Apr 30;22(8):1317-34. doi: 10.1002/sim.1433.

引用本文的文献

1
Bayesian multilevel multivariate logistic regression for superiority decision-making under observable treatment heterogeneity.基于可观测处理异质性的优势决策的贝叶斯多层多变量逻辑回归。
BMC Med Res Methodol. 2023 Oct 5;23(1):220. doi: 10.1186/s12874-023-02034-z.
2
Decision-making with multiple correlated binary outcomes in clinical trials.临床试验中具有多个相关二元结局的决策制定。
Stat Methods Med Res. 2020 Nov;29(11):3265-3277. doi: 10.1177/0962280220922256. Epub 2020 Jul 16.
3
Effect size measures and their benchmark values for quantifying benefit or risk of medicinal products.
用于量化药品益处或风险的效应量测量方法及其基准值。
Biom J. 2019 Jul;61(4):973-982. doi: 10.1002/bimj.201800107. Epub 2019 Feb 28.
4
Testing Mean Differences among Groups: Multivariate and Repeated Measures Analysis with Minimal Assumptions.检验组间均值差异:具有最小假设的多变量和重复测量分析。
Multivariate Behav Res. 2018 May-Jun;53(3):348-359. doi: 10.1080/00273171.2018.1446320. Epub 2018 Mar 22.
5
Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial.脑活素与卒中后恢复(CARS):一项随机、安慰剂对照、双盲、多中心试验。
Stroke. 2016 Jan;47(1):151-9. doi: 10.1161/STROKEAHA.115.009416. Epub 2015 Nov 12.